Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Mã chứng khoánINSP
Tên công tyInspire Medical Systems Inc
Ngày IPOMay 03, 2018
Giám đốc điều hànhMr. Timothy P. (Tim) Herbert
Số lượng nhân viên1246
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhMay 03
Địa chỉ5500 Wayzata Blvd Ste 1600
Thành phốGOLDEN VALLEY
Sàn giao dịch chứng khoánNYSE Consolidated
Quốc giaUnited States of America
Mã bưu điện55416-1237
Điện thoại17639575037
Trang webhttps://www.inspiresleep.com/
Mã chứng khoánINSP
Ngày IPOMay 03, 2018
Giám đốc điều hànhMr. Timothy P. (Tim) Herbert
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu